WEBSITE BSE:534535 NSE: META Inc. Year: 1994 Industry: Paper & Paper Products
Last updated: 00:00
Bio Green Papers Limited is a forward-thinking company specializing in the production of eco-friendly paper products. Established with a commitment to sustainability, the company utilizes recycled materials and innovative manufacturing processes to create high-quality paper that minimizes environmental impact. Bio Green Papers Limited focuses on a wide range of paper products, including writing paper, packaging materials, and specialty papers, catering to both commercial and consumer markets. The company prioritizes research and development to...Read More
Bio Green Papers Limited is a forward-thinking company specializing in the production of eco-friendly paper products. Established with a commitment to sustainability, the company utilizes recycled materials and innovative manufacturing processes to create high-quality paper that minimizes environmental impact. Bio Green Papers Limited focuses on a wide range of paper products, including writing paper, packaging materials, and specialty papers, catering to both commercial and consumer markets. The company prioritizes research and development to enhance product performance while reducing carbon footprint. By adopting environmentally responsible practices, Bio Green Papers Limited aims to promote a circular economy, ensuring that its products are not only functional but also contribute to the preservation of natural resources. With a strong emphasis on customer satisfaction and environmental stewardship, the company positions itself as a leader in the sustainable paper industry, addressing the growing demand for eco-friendly solutions in a rapidly changing world. ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹1483 Cr.
Stock P/E 42.1
P/B 5.3
Current Price ₹127.4
Book Value ₹ 24.2
Face Value 10
52W High ₹324.4
Dividend Yield 0%
52W Low ₹ 64.5
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 0 | 0 | 0 | 50 | 88 | 116 | 154 | 199 | 232 | 278 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 |
| Total Income | 0 | 0 | 0 | 50 | 88 | 116 | 154 | 199 | 233 | 279 |
| Total Expenditure | 0 | 0 | 0 | 43 | 80 | 104 | 138 | 177 | 207 | 247 |
| Operating Profit | 0 | 0 | 0 | 7 | 8 | 12 | 16 | 22 | 26 | 32 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 1 | 1 | 2 | 3 | 3 | 4 | 4 |
| Exceptional Income / Expenses | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -0 | -0 | -1 | 5 | 7 | 10 | 13 | 18 | 22 | 28 |
| Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | -0 | -0 | -1 | 5 | 7 | 10 | 13 | 18 | 22 | 28 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | -0 | -0 |
| Profit After Adjustments | -0 | -0 | -1 | 5 | 7 | 10 | 13 | 18 | 21 | 28 |
| Adjusted Earnings Per Share | -0 | -0 | -0.3 | 0.5 | 0.6 | 1 | 1.2 | 1.6 | 1.8 | 2.4 |
| #(Fig in Cr.) | Mar 2019 | Mar 2020 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|
| Net Sales | 10 | 10 | 0 | 151 | 407 | 863 |
| Other Income | 0 | 0 | 0 | 1 | 1 | 1 |
| Total Income | 10 | 10 | 0 | 152 | 408 | 865 |
| Total Expenditure | 9 | 9 | 1 | 138 | 366 | 769 |
| Operating Profit | 1 | 1 | -1 | 14 | 42 | 96 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 2 | 7 | 14 |
| Exceptional Income / Expenses | 1 | 0 | 0 | -1 | 0 | 0 |
| Profit Before Tax | 0 | -0 | -1 | 11 | 35 | 81 |
| Provision for Tax | 0 | -0 | -0 | 0 | 0 | 0 |
| Profit After Tax | 0 | -0 | -1 | 11 | 35 | 81 |
| Adjustments | 0 | 0 | 0 | 0 | -0 | 0 |
| Profit After Adjustments | 0 | -0 | -1 | 11 | 35 | 80 |
| Adjusted Earnings Per Share | 0.2 | -0.1 | -0.5 | 1.1 | 3.3 | 7 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 170% | 244% | 0% | 0% |
| Operating Profit CAGR | 200% | 248% | 0% | 0% |
| PAT CAGR | 218% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 88% | 313% | 121% | 56% |
| ROE Average | 26% | 11% | 7% | 7% |
| ROCE Average | 26% | 11% | 7% | 7% |
| #(Fig in Cr.) | Mar 2019 | Mar 2020 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Shareholder's Funds | 49 | 48 | 36 | 110 | 161 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 2 | 5 | 4 | 0 | 0 |
| Other Non-Current Liabilities | 2 | 2 | 1 | 1 | 0 |
| Total Current Liabilities | 2 | 3 | 1 | 5 | 2 |
| Total Liabilities | 55 | 58 | 42 | 117 | 163 |
| Fixed Assets | 19 | 17 | 11 | 64 | 124 |
| Other Non-Current Assets | 28 | 27 | 28 | 7 | 16 |
| Total Current Assets | 9 | 14 | 2 | 45 | 24 |
| Total Assets | 55 | 58 | 42 | 117 | 163 |
| #(Fig in Cr.) | Mar 2019 | Mar 2020 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 0 | 0 | 24 |
| Cash Flow from Operating Activities | 0 | 0 | -0 | -1 | 49 |
| Cash Flow from Investing Activities | 0 | 0 | 0 | -25 | -75 |
| Cash Flow from Financing Activities | 0 | 0 | 0 | 50 | 12 |
| Net Cash Inflow / Outflow | 0 | 0 | -0 | 24 | -14 |
| Closing Cash & Cash Equivalent | 0 | 0 | 0 | 24 | 10 |
| # | Mar 2019 | Mar 2020 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 0.18 | -0.14 | -0.53 | 1.12 | 3.28 |
| CEPS(Rs) | 0.66 | 0.4 | -0.3 | 1.34 | 3.92 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 18.86 | 18.71 | 13.99 | 11.38 | 14.94 |
| Core EBITDA Margin(%) | 9.6 | 11.08 | 0 | 8.56 | 10.14 |
| EBIT Margin(%) | 6.48 | -1.55 | 0 | 7.2 | 8.69 |
| Pre Tax Margin(%) | 4.7 | -4.25 | 0 | 7.15 | 8.68 |
| PAT Margin (%) | 4.66 | -3.6 | 0 | 7.15 | 8.65 |
| Cash Profit Margin (%) | 17.18 | 10.3 | 0 | 8.6 | 10.31 |
| ROA(%) | 0.85 | -0.64 | -6.52 | 13.67 | 25.18 |
| ROE(%) | 0.95 | -0.74 | -7.52 | 14.76 | 26.09 |
| ROCE(%) | 1.24 | -0.29 | -7.06 | 14.46 | 26.04 |
| Receivable days | 210.02 | 258.6 | 0 | 3.49 | 1.34 |
| Inventory Days | 141.14 | 123.59 | 0 | 0 | 0 |
| Payable days | 37.73 | 32.1 | 102.86 | 0 | 0 |
| PER(x) | 17.78 | 0 | 0 | 0 | 29.05 |
| Price/Book(x) | 0.17 | 0.09 | 0 | 0 | 6.38 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 1.18 | 1.1 | 0 | 0.49 | 2.48 |
| EV/Core EBITDA(x) | 12.23 | 8.91 | -35.47 | 5.32 | 23.94 |
| Net Sales Growth(%) | 0 | 0.14 | 0 | 0 | 169.4 |
| EBIT Growth(%) | 0 | -123.97 | 0 | 871.13 | 225.18 |
| PAT Growth(%) | 0 | -177.32 | 0 | 895.92 | 225.9 |
| EPS Growth(%) | 0 | -177.28 | -278.36 | 311.93 | 194.09 |
| Debt/Equity(x) | 0.07 | 0.14 | 0.11 | 0 | 0 |
| Current Ratio(x) | 4.01 | 5.48 | 4.09 | 9.91 | 14.07 |
| Quick Ratio(x) | 2.2 | 4.34 | 2.55 | 9.91 | 14.07 |
| Interest Cover(x) | 3.64 | -0.57 | 0 | 141.09 | 473.52 |
| Total Debt/Mcap(x) | 0.43 | 1.57 | 0 | 0 | 0 |
| # | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 25.57 | 25.57 | 25.57 | 25.57 | 88.99 | 89.03 | 89.03 | 81.79 | 81.79 | 81.79 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0 |
| Public | 74.43 | 74.43 | 74.43 | 74.43 | 11.01 | 10.97 | 10.97 | 18.21 | 18.19 | 18.21 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.66 | 0.66 | 0.66 | 0.66 | 9.52 | 9.52 | 9.52 | 9.52 | 9.52 | 9.52 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 1.92 | 1.92 | 1.92 | 1.92 | 1.18 | 1.17 | 1.17 | 2.12 | 2.12 | 2.12 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2.58 | 2.58 | 2.58 | 2.58 | 10.7 | 10.7 | 10.7 | 11.64 | 11.64 | 11.64 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
